$55.46 +1.97 (3.68%) Clovis Oncology Inc - NASDAQ

Jan. 13, 2017 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 55.46
Trade Time: Jan 13 04:00 PM Eastern Daylight Time
Change: +1.97 (3.68%)
Prev Close: 53.49
Open: 54.15
Bid: 55.44
Ask: 55.46
  1. Conatus Soars On Novartis Deal, Early FDA Nod For Clovis Drug

    TalkMarkets | Dec. 21, 2016 | 10:55AM EST
  2. Tesaro Ovarian Cancer Drug Gets Priority Review After FDA OKs Clovis Med

    Investors Business Daily | Dec. 20, 2016 | 11:28AM EST
  3. Biotechs Fade Again In Late Day Sell-Off

    TalkMarkets | Dec. 19, 2016 | 20:51PM EST
  4. Clovis Jumps After Securing FDA Approval For Ovarian Cancer Drug

    TalkMarkets | Dec. 19, 2016 | 17:18PM EST
  5. Supernus Pharmaceuticals Breaks Out On Up Day For Biotech Stocks

    Investors Business Daily | Dec. 19, 2016 | 13:48PM EST
  6. Stocks Higher As 3 Medicals Hit Buy Points; No 'Star Wars' Bump For Hasbro

    Investors Business Daily | Dec. 19, 2016 | 13:37PM EST
  7. Clovis Stock Rallies After AstraZeneca-Rivaling Ovarian Cancer Win

    Investors Business Daily | Dec. 19, 2016 | 13:28PM EST
  8. Ariad Pharma Could Draw M&A Fire Ahead Of Second Cancer Drug Win

    Investors Business Daily | Dec. 7, 2016 | 15:20PM EST
  9. Biotech Stock Roundup: Alnylam Slumps On Revusiran Update, TESARO Impresses At ESMO

    TalkMarkets | Oct. 12, 2016 | 11:14AM EST
  10. Poor Stock Action & Trading

    TalkMarkets | Oct. 11, 2016 | 18:21PM EST
  11. 6 Best Performing Drug Stocks Of September 2016

    TalkMarkets | Oct. 3, 2016 | 12:05PM EST
  12. 5 Top Performing Stocks Of The Best ETF Of Q3

    TalkMarkets | Sep. 30, 2016 | 10:47AM EST
  13. Gilead Slips As Former Bull Turns Bearish On Hep C Business

    TalkMarkets | Sep. 27, 2016 | 14:10PM EST
  14. Benzinga's Top Initiations

    Benzinga | Dec. 17, 2015 | 10:02AM EST
  15. Clovis Oncology Receives Notification of PDUFA Extension for Rociletinib

    Benzinga | Dec. 15, 2015 | 16:16PM EST
Trading Center